Literature DB >> 11845018

Chondral injuries.

Robert A Sellards1, Shane J Nho, Brian J Cole.   

Abstract

Chondral injures are present in up to 10 to 12% of all individuals. When symptomatic, chondral lesions manifest in knee pain, swelling, and loss of function. Cartilage loss may be partial or complete, and it may affect one or multiple locations. The natural history of untreated lesions most likely results in increased disability and progression of cartilage loss. Lesions are classified according to location, depth, and size. Nonsurgical treatment modalities include oral medications, injections, bracing, or physical therapy. Surgical treatment ranges from arthroscopic debridement to implantation of autologous chondrocytes beneath a periosteal patch covering the lesion. The patient's symptoms, age, activity level, and lesion characteristics must be considered and matched with a suitable procedure.

Entities:  

Mesh:

Year:  2002        PMID: 11845018     DOI: 10.1097/00002281-200203000-00010

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  13 in total

Review 1.  Building bridges: leveraging interdisciplinary collaborations in the development of biomaterials to meet clinical needs.

Authors:  Eliza L S Fong; Brendan M Watson; F Kurtis Kasper; Antonios G Mikos
Journal:  Adv Mater       Date:  2012-07-23       Impact factor: 30.849

2.  Effects of the combination of microfracture and self-assembling Peptide filling on the repair of a clinically relevant trochlear defect in an equine model.

Authors:  Rachel E Miller; Alan J Grodzinsky; Myra F Barrett; Han-Hwa Hung; Eliot H Frank; Natasha M Werpy; C Wayne McIlwraith; David D Frisbie
Journal:  J Bone Joint Surg Am       Date:  2014-10-01       Impact factor: 5.284

3.  Avascular necrosis complicating chondral resurfacing techniques.

Authors:  Simon M Thompson; Anja Saso; Parag Raval; Mary Jones; Andrew M Williams
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-07-23       Impact factor: 4.342

4.  Adjacent cartilage tissue structure after successful transplantation: a quantitative MRI study using T2 mapping and texture analysis.

Authors:  Veronika Janacova; Pavol Szomolanyi; Alexandra Kirner; Siegfried Trattnig; Vladimir Juras
Journal:  Eur Radiol       Date:  2022-06-23       Impact factor: 5.315

5.  Photoactivated platelet-rich plasma therapy for a traumatic knee chondral lesion.

Authors:  Julien Freitag; Adele Barnard; Andrew Rotstein
Journal:  BMJ Case Rep       Date:  2012-12-17

6.  Matrix-induced autologous chondrocyte implantation versus microfracture in the treatment of cartilage defects of the knee: a 2-year randomised study.

Authors:  Erhan Basad; Bernd Ishaque; Georg Bachmann; Henning Stürz; Jürgen Steinmeyer
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-04       Impact factor: 4.342

7.  Patient Outcomes After Observation Versus Debridement of Unstable Chondral Lesions During Partial Meniscectomy: The Chondral Lesions And Meniscus Procedures (ChAMP) Randomized Controlled Trial.

Authors:  Leslie J Bisson; Melissa A Kluczynski; William M Wind; Marc S Fineberg; Geoffrey A Bernas; Michael A Rauh; John M Marzo; Zehua Zhou; Jiwei Zhao
Journal:  J Bone Joint Surg Am       Date:  2017-07-05       Impact factor: 5.284

8.  Reconstruction of osteochondral defects by combined bone grafting and a bilayer collagen membrane as a sandwich technique.

Authors:  Maximilian Petri; Max Ettinger; Christian von Falck; Nael Hawi; Michael Jagodzinski; Carl Haasper
Journal:  Orthop Rev (Pavia)       Date:  2013-11-18

9.  Repair of a chondral defect using a cell free scaffold in a young patient--a case report of successful scaffold transformation and colonisation.

Authors:  Karl F Schüettler; Johannes Struewer; Marga B Rominger; Peter Rexin; Turgay Efe
Journal:  BMC Surg       Date:  2013-04-16       Impact factor: 2.102

10.  Individual and occupational risk factors for knee osteoarthritis - study protocol of a case control study.

Authors:  André Klussmann; Hansjuergen Gebhardt; Falk Liebers; Lars Victor von Engelhardt; Andreas Dávid; Bertil Bouillon; Monika A Rieger
Journal:  BMC Musculoskelet Disord       Date:  2008-02-26       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.